Latest Operational Outlook News

Gibb River Diamonds has officially started mining operations at its Edjudina Gold Project in Western Australia, leveraging a contract mining model that shields the company from upfront costs. The Neta Prospect's gold production will be processed through toll milling agreements, with profits shared equally between Gibb River and contractor BML Ventures.

Austral Gold has obtained a $1 million short-term loan to support working capital as its Casposo processing plant nears commissioning after major refurbishments.

TasFoods reports a $3.6 million net loss for H1 2025, impacted by oversupply and discounted poultry prices, while advancing key initiatives including pet treats expansion and planned divestments.

Senetas Corporation has reported a transformative FY2025 with a $27.8 million net profit driven by the divestment of its Votiro business, while its core network encryption operations remain profitable and cash generative.

Iris Cairns Property Pty Ltd has lodged a bidder’s statement for an all-cash $3.87 per unit takeover offer for Reef Casino Trust, securing unanimous recommendation from the trust’s board and major unitholders. The offer, representing a significant premium, awaits regulatory approvals and closes in March 2026.

Hydrix Limited narrowed its FY2025 loss to $2.92 million, driven by significant cost reductions and steady revenue from expanding international medtech clients. Despite ongoing challenges in sales cycles and funding, the company remains focused on innovation and strategic investments.

Vinyl Group Ltd reports a striking 190% revenue increase in FY25, driven by acquisitions and organic growth, while preparing for its first EBITDA positive quarter by December 2025.

Ovanti Limited’s FY2025 results reveal a modest revenue dip but a sharp 61% rise in net loss, driven by a significant impairment charge. The company’s capital base strengthened despite ongoing losses, with no dividends declared.

Phoslock Environmental Technologies reports a sharp revenue increase driven by Brazil and international markets, yet continues to face significant losses and ongoing legal challenges.

Harvey Norman Holdings Limited reported strong FY25 financial results, driven by growth in franchisee sales, property portfolio appreciation, and digital investments. The company’s integrated retail, franchise, property, and digital system across multiple countries underpins its sustained shareholder returns.

Percheron Therapeutics posted a 25% increase in net loss for FY2025 amid termination of its Duchenne Muscular Dystrophy programs. The company pivots strategically to oncology with the in-licensing of HMBD-002, a monoclonal antibody targeting VISTA, aiming to initiate Phase II trials in 2026.

Hartshead Resources has voluntarily suspended trading on the ASX pending a significant announcement about a well carry agreement linked to its P2607 Licence. The suspension is set to last until the announcement or early September.